US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
オーストラリア
ASX
Tribune Resources Limited (TBR) 銘柄情報

Tribune Resources Limited (TBR)

5.23

-0.07

(-1.32%)

終了 6月13日 3:00PM

Tribune Resources Limited (TBR) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

5.23

( -1.32% )

買値

5.10

売値

5.50

出来高

17,075

5.23 日の範囲 5.34

4.42 52 週間の範囲 7.59

時価総額

前日終値

5.30

始値

5.34

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

AUD 15,220

発行済株式数

52,468,077

配当利回り

0.2 (3.41%)

PER

6.99

1 株当たり利益 (EPS)

0.84

歳入

166.1M

純利益

44.24M

Tribune Resources Limited, together with its subsidiaries, engages in the development, exploration, and production of mineral properties in Australia. It primarily explores for gold and silver deposits. The company holds interests in the East Kundana joint venture and the West Kundana joint venture ... Tribune Resources Limited, together with its subsidiaries, engages in the development, exploration, and production of mineral properties in Australia. It primarily explores for gold and silver deposits. The company holds interests in the East Kundana joint venture and the West Kundana joint venture located in Western Australia; and the Japa project located in Ghana, West Africa. It also holds an interest in Diwalwal Gold Project situated in Davao City Mindanao Island, Philippines. Tribune Resources Limited was incorporated in 1988 and is based in South Perth, Australia. 詳細を表示

セクター

Materials

業界

Mining

ウェブサイト

tribune.com.au

本社

South Perth, Australia

設立

1988

Tribune Resources Limited is listed in the Materials sector of the オーストラリア証券取引所 with ticker TBR. The last closing price for Tribune Resources was AUD5.30. Over the last year, Tribune Resources shares have traded in a share price range of AUD 4.42 to AUD 7.59.

Tribune Resources currently has 52,468,077 shares in issue. The market capitalisation of Tribune Resources is AUD274.41 million. Tribune Resources has a price to earnings ratio (PE ratio) of 6.99.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.25	-4.56204379562	5.48	5.86	5.23	6454	5.61454677	DE
4	-0.08	-1.5065913371	5.31	5.93	5.22	13761	5.4338118	DE
12	-0.65	-11.0544217687	5.88	6	5.13	15115	5.51442964	DE
26	-1.06	-16.8521462639	6.29	7.2	5.13	18036	6.11029742	DE
52	0.31	6.30081300813	4.92	7.59	4.42	18230	6.16608189	DE
156	1.83	53.8235294118	3.4	7.59	2.48	16487	4.65714113	DE
260	0.13	2.54901960784	5.1	7.59	2.48	12938	4.56964998	DE

TBR - Frequently Asked Questions (FAQ)

What is the current Tribune Resources Limited share price?

The current share price of Tribune Resources Limited is AUD 5.23

How many Tribune Resources Limited shares are in issue?

Tribune Resources Limited has 52,468,077 shares in issue

What is the market cap of Tribune Resources Limited?

The market capitalisation of Tribune Resources Limited is AUD 274.41M

What is the 1 year trading range for Tribune Resources Limited share price?

Tribune Resources Limited has traded in the range of AUD 4.42 to AUD 7.59 during the past year

What is the PE ratio of Tribune Resources Limited?

The price to earnings ratio of Tribune Resources Limited is 6.99

What is the cash to sales ratio of Tribune Resources Limited?

The cash to sales ratio of Tribune Resources Limited is 1.85

What is the registered address of Tribune Resources Limited?

The registered address for Tribune Resources Limited is 49 Melville Parade, South Perth, Western Australia, 6151

What is the Tribune Resources Limited website address?

The website address for Tribune Resources Limited is tribune.com.au

Which industry sector does Tribune Resources Limited operate in?

Tribune Resources Limited operates in the Mining sector

81vette

81vette 9分前

I understand now,merger had a 20 day mandatory waiting period,it ended and merger was complete and new company’s first day was Thursday,Friday was 1st day of some institutional buying (burst basket trades) Monday could be really good ,I bet updates/PRs will be often now.
We made it thru the

RockQQ

RockQQ 10分前

Wow, we always suspected! Good link!

RockQQ

midastouch017

midastouch017 12分前

I came to the sad conclusion that discussing
RDHL is a sheer waste of time!
:-(

MartinLutherKing

MartinLutherKing 13分前

The short song and dance is over rockafella, You just can’t get em cheapies so easily.. You got to pay to play in the big leagues

janice shell

janice shell 22分前

Oh yes, I remember. It's a pretty color. And they're very useful.

I may not be able to resist. It really IS a fabulous value. The reviewers seem to like it.

surfer44

surfer44 23分前

2026 10th Capital Link Maritime Leaders Summit – Greece | Dry Bulk at an Inflection Point

https://youtu.be/adh3JnRr8qo

Whalatane

Whalatane 27分前

My debate with Claude
Velphoro leaves 100% TDAPA reimbursement Dec 31st 2026 . OLC if approved starts 100% reimbursement ...so won't Fresenius want to switch patients to OLC especially if licensed by CSL Vifor9:44 PM

????Claude responded:
That changes the calculus mean

shajandr

shajandr 28分前

I bought this one in 2025 and am pleased with it so far.

https://investorshub.advfn.com/uimage/uploads/2026/6/13/xfifamueller.JPG

https://www.amazon.com/dp/B0DRDNZDHK?ref=ppx_yo2ov_dt_b_fed_asin_title&th=1

BTW, when I put the bunnies' food ~OUTT under the

jour_trader

jour_trader 30分前

lol there was no waiver. Glad you are now caught up on the real timeline.

wadegarret

wadegarret 34分前

Valuemind- SNDK

Are you not concerned that despite only a 11-12 PE going forward, that this is a highly cyclical stock up from $30 a year ago ? I mean in other words, if judging the value of a stock today is based on future earnings going out at least 2-3 years, how can one have

Whalatane

Whalatane 37分前

Searched the webHere's the mechanism if OLC (Renazorb) gets FDA approval and TDAPA designation:...via Claude

Normal economics without TDAPA:
Phosphate binders fall inside Medicare's ESRD bundled payment (~$281.71/treatment). Any drug a clinic uses comes out of that fixed bund

mmayr

Complete Meltdown is Coming

https://youtu.be/5sp1minxEns?is=-W1we0evirBu6yX9

boston127

boston127 44分前

Something good is happening here.

I'm not dumping, just trying to sell high and buy low.

shajandr

shajandr 45分前

As you've nott replied to my questions (perhaps you, like many/most others have me on Ignore), infra, prolly in view of there being no meritorious argument supporting the SEC's so-kalt 'gag rule' on settlements, I've restructured my inquiry. I'd still enjoy reading your reply to the original questio

janice shell

janice shell 45分前

I'll bet you can even get ivermectin at Amazon now. You can get everything at Amazon.

Damn, should I get this? It's tempting. Fantastic price:

https://investorshub.advfn.com/uimage/uploads/2026/6/13/vujmmimage.jpeg

https://www.amazon.com/EDGING-CASTING-En

bim524

bim524 46分前

Maybe you should go to an Amazon board and complain over there Instead of spreading this nonsense about a fake agreement here. If you even had any semblance of historical fact you would pretend to know that this company won’t even name companies in their PRs… if they issue a statement that says ther

Just give me $1.50

Just give me $1.50 47分前

Huh?

You haven't been watching and/or listening to the news?

Because of peace talks failing, and the War in Iran restarting, Elite submitted a waiver request to the SEC to have their 10-K filing deadline pushed back by two weeks due to safety concerns.

It

HyGro

No biotech passes on the chance for an FDA approval -- NWBO sure did and likely because FDA told them not to bother. No oncology drug can be very profitable with out U.S. approval. NWBO didn't even try. Why, because they knew they wouldn't get accepted. Just watch, NWBO won't apply for FDA

grantastic

grantastic 49分前

It is crazy to believe that HDUP is pursuing any legitimate business deals.

Especially after Mark Hutchison scrubbed all mention of HDUP from his professional profile. He's moved on from the scam. Shareholders need to move on too.

The only evidence ever shown of these

sandor8

sandor8 49分前

It is only proving to itself to be part of the group of psychopath an sociopath world over known today, only needing a driver of a tank to hint physically to them that our essence can be flattened, quite simplifying and ameliorating the other's existence.

normal investor

normal investor 53分前

Just give me $1.50

Just give me $1.50 53分前

LMAO.

1-2 years?

You mean 1-2 ............. WEEKS?

Shareholder: "Is the timeline for uplisting to NASDAQ or acquisition merger still on track to be around August 2026?"

Nasrat: "NO!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!"

nowwhat2

nowwhat2 58分前

https://investorshub.advfn.com/uimage/uploads/2026/6/13/kgwzibtc_june_12_zoom_cup_depend.jpghttps://investorshub.advfn.com/uimage/uploads/2026/6/13/wvapvdepend_sikh.jpg

.

mrwrn2010

mrwrn2010 1時間前

What I’m reading seems to indicate that Elite is still not prevented from obtaining *tentative approval* from the FDA on the OxyContin ANDA, only that they can’t get final approval until/after 8/24/27. I believe Nasrat also confirmed this last call. Ideally, we see a tentative Oxy approval sometime

Tribune Resources

Carlyle Group Inc The

3x Long Coupang

2.75% Grn Trns Nts 20/12...

Global X Uranium UCITS E...

Prudential Financial

AfterNext HealthTech Acq...

Ci Canadian Investment C...

Clean Seas Seafood

Caja De Ahorro Del Medit...

Impel Pharmaceuticals

Piper Sandler Companies

Banco Bilbao Vizcaya Arg...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。